CORRECTION - atai Life Sciences to Announce First Quarter 2022 Financial Results and Business Update
06 May 2022 - 5:19AM
In a release issued yesterday under the headline "atai Life
Sciences to Announce First-Quarter 2022 Financial Results" by atai
Life Sciences N.V. (Nasdaq: ATAI), please note the first and second
paragraphs, which contained statements referencing the 2022 IR
financial results posting and executives on the video interview, as
well as forward-looking statements, have been modified. The
corrected release follows:
atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a
clinical-stage biopharmaceutical company aiming to transform the
treatment of mental health disorders, plans to announce its first
quarter 2022 financial results and business update on Monday, May
16, 2022.
A video interview with atai management will be available at 8:30
a.m. (ET) at https://vimeo.com/atailifesciences. The archived
video interview will be available in the “Events” section of the
atai website at https://www.atai.life/.
About atai Life Sciences
atai Life Sciences is a clinical-stage biopharmaceutical company
aiming to transform the treatment of mental health disorders.
Founded in 2018 as a response to the significant unmet need and
lack of innovation in the mental health treatment landscape, atai
is dedicated to acquiring, incubating, and efficiently developing
innovative therapeutics to treat depression, anxiety, addiction,
and other mental health disorders.
atai's business model combines funding, technology, scientific,
and regulatory expertise with a focus on innovative compounds,
including psychedelic therapy and other drugs with differentiated
safety profiles and therapeutic potential. By pooling resources and
best practices, atai aims to responsibly accelerate the development
of new medicines across its companies to achieve clinically
meaningful and sustained behavioral change in mental health
patients.
atai's vision is to heal mental health disorders so that
everyone, everywhere can live a more fulfilled life. atai has
offices in New York, San Diego, Boston, London, and Berlin. For
more information, please visit https://www.atai.life/.
Contact Information
Investor Contact:Greg WeaverChief Financial
OfficerEmail: greg.weaver@atai.life
Media Contact:Maggie Gordon Senior Manager,
CommunicationsEmail: maggie@atai.life
ATAI Life Sciences NV (NASDAQ:ATAI)
Historical Stock Chart
From Mar 2024 to Apr 2024
ATAI Life Sciences NV (NASDAQ:ATAI)
Historical Stock Chart
From Apr 2023 to Apr 2024